Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.
Cardiology August 5th 2024
Medical Xpress
Incidence rates provide a truer measure of medication-induced liver injury, revealing misclassifications in traditional methods. This study highlights the need for closer monitoring of certain medications using real-world healthcare data.
Hepatology July 2nd 2024
Cleveland Clinic Journal of Medicine (CCJM)
Cardiac complications significantly influence the success of liver transplants. Effective preoperative cardiac risk stratification and careful intraoperative management are essential to optimize patient outcomes.
Cardiology May 16th 2024
This analysis of a PBC patient’s complex lipid profile underscores the importance of diagnosing the specific types of xanthomas, as they are directly indicative of underlying dyslipidemias, which require tailored therapeutic approaches.
Dermatology April 17th 2024
In the evolving landscape of liver disease management, timely diagnosis and tailored treatment strategies for ascites and spontaneous bacterial peritonitis stand as pivotal elements in enhancing patient survival and quality of life, underscoring the necessity of adherence to updated guidelines.
Gastroenterology April 3rd 2024
MedTech Dive
Better Therapeutics’ digital therapeutic app has been recognized with FDA breakthrough device status, showcasing its potential in significantly reducing liver fat in patients with advanced liver disease through cognitive behavioral therapy.
Gastroenterology February 26th 2024